Researchers at the Anglia Ruskin University (ARU) in the U.K. have made significant progress in treating cataracts using a drug compound, paving the way for new treatment methods.
A cataract is a medical condition where the eye’s lens becomes clouded over some time and affects vision quality. The clouding is caused by the disorganization of the proteins present in the lens. This eventually leads to their clumping, which scatters light away from the retina, thereby reducing vision. According to estimates from the World Health Organization (WHO), the condition affects approximately 65 million people globally, with moderate to severe vision loss seen in about 80 percent of the cases.
Find out more at https://bit.ly/3PsfkDl
#Engineering
